Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection
Clinical trial NCT00582738 · TERMINATED
Trial details
- NCT number
- NCT00582738
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-01-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.